"SFDA" Hosts the International Regulatory Commission of Herbal Drugs (RCH) Meetings

<p class="ms-rteElement-P" style="text-align:justify"><div> </div>
<div> </div> </p>
<p class="ms-rteElement-P" style="text-align:justify">His Excellency the Chief Executive Officer
of SFDA, Dr. Mohammed bin Abdulrahman Al Mishal Inaugurated the International Regulatory
Commission of Herbal Drugs (IRCH) meeting, in the presence of 33 professionals
from Riyadh.</p>
<p class="ms-rteElement-P" style="text-align:justify">Dr. Al Mishal Said in his opening speech of
the meeting, held under the auspices of SFDA and in cooperation with the World
Health Organization (WHO): &quot;I am delighted to welcome you to this unique
meeting, which brings together representatives from international regulatory
and Authorities in the field of drug and World Health Organization, to share
information and experiences about herbal products and adoption of international
best practices to ensure quality, safety and efficacy &quot;</p>
<p class="ms-rteElement-P" style="text-align:justify">To
this effect, the medical coordinator of the Complementary Alternative Medicine
at  the World Health Organization, Dr.
Zhang Kyi, thanked SFDA for hosting the Organization meeting, and looked
forward for organization to benefit from the  meeting Saudi Arabia and the Kingdom’s
experience in the field of herbal drugs regulation.</p>
<p class="ms-rteElement-P" style="text-align:justify">Dr. Zhang pointed out to the importance of
participating in such scientific meetings that are held annually, and resulting
in  blending different experiences around
the world<span lang="AR-SA" dir="RTL">.</p>
<p class="ms-rteElement-P" style="text-align:justify">The meeting aims to identify and discuss priorities
related to the quality, safety and efficacy of herbal medicines issues, and to
explore problems related to quality, safety and efficacy of herbal medicine,
and to find the appropriate solutions and to review and assess the activities
of the organization’s groups during the previous years, and to identify
priorities, actions, and propose activities for the following year, and discuss
the development programs available to (MedNet) members which allow discussions
and share important information in a secure manner in the gield of regulation
and registration of herbal products<span lang="AR-SA" dir="RTL">.</p>
<p class="ms-rteElement-P" style="text-align:justify">It worth mentioning that the International
Regulatory Commission of Herbal Drugs (IRCH), is managed by the World Health
Organization (WHO), and its meetings are held regularly every year. The
beginning was when the organization only held collective workshops for
regulations development to address herbal medicines. in November 2005 in
Ottawa, Canada, the meeting was attended by representatives from 16 countries.  The participants agreed on the establishment
of the International Regulatory Commission of Herbal Drugs (IRCH).</p>
<p class="ms-rteElement-P" style="text-align:justify">The first actual meeting was held in October
2006 in China, and the Kingdom joined the Organization membership in 2009<span lang="AR-SA" dir="RTL">.</p>
<p class="ms-rteElement-P" style="text-align:justify">Currently the organization consists of 31
members. Membership ia represented by attendants of representatives of each
country or the following groups (Argentina, Armenia, ASEAN, Australia, Brazil,
Brunei Darussalam, Canada, China, Hong Kong, Cuba, European Union, Ghana,
Hungary , India, Indonesia, Japan, Malaysia, Mexico, Oman, Pakistan, Latin
America, Peru, Portugal, South Korea, Singapore, Tanzania, Saudi Arabia, United
Arab Emirates, United Kingdom, United States of America, and the World Health
Organization).</p>
<div>

 </div>
<p class="ms-rteElement-P" style="text-align:justify"><br /> </p>